U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C28H29N5O3
Molecular Weight 483.5616
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LECOZOTAN

SMILES

C[C@H](CN(C(=O)C1=CC=C(C=C1)C#N)C2=NC=CC=C2)N3CCN(CC3)C4=C5OCCOC5=CC=C4

InChI

InChIKey=NRPQELCNMADTOZ-OAQYLSRUSA-N
InChI=1S/C28H29N5O3/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23/h2-12,21H,13-18,20H2,1H3/t21-/m1/s1

HIDE SMILES / InChI

Molecular Formula C28H29N5O3
Molecular Weight 483.5616
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

LECOZOTAN, a benzodioxanylpiperazine derivative, is a selective serotonin 1A receptor antagonist. It was in development for the symptomatic treatment of cognitive deficits in Alzheimer's disease.

Approval Year

PubMed

PubMed

TitleDatePubMed
Drug development for Alzheimer's disease: recent progress.
2010-12
Acute lecozotan administration increases learning and memory in rats without affecting anxiety or behavioral depression.
2010-05
Bilobalide modulates serotonin-controlled behaviors in the nematode Caenorhabditis elegans.
2009-06-22
Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects.
2009-03
A positron emission tomography study to assess binding of lecozotan, a novel 5-hydroxytryptamine-1A silent antagonist, to brain 5-HT1A receptors in healthy young and elderly subjects, and in patients with Alzheimer's disease.
2008-01
Progress update: Pharmacological treatment of Alzheimer's disease.
2007
Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties.
2005-09
Synthesis and biological evaluation of benzodioxanylpiperazine derivatives as potent serotonin 5-HT(1A) antagonists: the discovery of Lecozotan.
2005-05-19
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:04:18 GMT 2025
Edited
by admin
on Mon Mar 31 18:04:18 GMT 2025
Record UNII
48854OTZ5E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LECOZOTAN
INN  
INN  
Official Name English
lecozotan [INN]
Preferred Name English
4-CYANO-N-((2R)-2-(4-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)PIPERAZIN-1-YL)PROPYL)-N-(PYRIDIN-2-YL)BENZAMIDE
Systematic Name English
BENZAMIDE, 4-CYANO-N-((2R)-2-(4-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)-1-PIPERAZINYL)PROPYL)-N-2-PYRIDINYL-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66885
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
Code System Code Type Description
PUBCHEM
10116877
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
SMS_ID
100000126191
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
FDA UNII
48854OTZ5E
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
CAS
434283-16-6
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
MESH
C500836
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
WIKIPEDIA
LECOZOTAN
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL372205
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
EVMPD
SUB33289
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
INN
8489
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
EPA CompTox
DTXSID30870354
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
NCI_THESAURUS
C74394
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
DRUG BANK
DB12540
Created by admin on Mon Mar 31 18:04:19 GMT 2025 , Edited by admin on Mon Mar 31 18:04:19 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY